The Brazilian Journal of Infectious Diseases
Cancer-type oatp1b3-V1 is a functional plasma membrane transporter mediating increased uptake of chemotherapeutics in vitro and in vivo
Lorestani, S., Bahari, A., Asadi, M., & Zahedi Avval, F
Zepbound users lost up to 22.5% of body weight in clinical trials, while Ozempic users lost an average of about 14.9% Zepbound works on two receptors (GIP and GLP-1), giving it stronger effects on weight and blood sugar Both medications share similar side effects, mostly stomach-related symptoms Cost and insurance coverage vary widely, making accessibility a major factor in choosing between them Long-term use is required for both drugs to maintain results Choosing between Zepbound and Ozempic is a decision millions of people face when starting their weight loss journey
Post-reconstitution storage protocols should be followed precisely
These phenomena might be closely related to DNA damage, one of the causes of ferroptosis induced due to lipid peroxidation